mesylate, a quinazoline compound sold by Pfizer under the brand names cardura doxazosin mesylate 1 mg and Carduran® , is an alpha-1 adrenergic receptor blocker which inhibits the binding of norepinephrine to alpha receptors in the autonomic nervous system. The primary effect of this blockage is relaxed vascular cardura doxazosin mesylate 1 mg muscle tone.

life 22 cardura doxazosin mesylate 1 mg ?Therapeutic considerationsPregnancy cat. ?Legal status ? Prescription onlyRoutes oralDoxazosin mesylate, a quinazoline compound sold by Pfizer under the brand names Cardura® and Carduran® , is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, to cardura doxazosin mesylate 1 mg marketed as Cardura® XL.It is an alpha-1 adrenergic receptor blocker which inhibits the binding of norepinephrine to alpha receptors in the autonomic nervous cardura doxazosin mesylate 1 mg The primary effect of this blockage is relaxed vascular smooth muscle tone (vasodilation), cardura doxazosin mesylate 1 mg cardura doxazosin mesylate 1 mg peripheral vascular resistance, leading to decreased blood pressure. cardura doxazosin mesylate 1 mg Wikipedia, the free encyclopedia(Redirected from Cardura)Jump to: navigation, searchDoxazosinSystematic (IUPAC) name[4-(4-amino-6,7-dimethoxy- quinazolin-2-yl) piperazin-1-yl]- (2,5-dioxabicyclo[4.4.0] deca-6,8,10-trien-4-yl) methanoneIdentifiersCAS number 74191-85-8ATC code.

cat. ?Legal status cardura doxazosin mesylate 1 mg Prescription onlyRoutes oralDoxazosin mesylate, a quinazoline compound sold by Pfizer under the brand names Cardura®.